Page 17 - Bharat Biotech

India Coronavirus Dispatch: New computational tool to track Covid mutations

Parents more ready to send kids to school, trial candidates wonder if they got vaccine or placebo, Antibodies appear faster if exposed to virus earlier-news relevant to India's fight against Covid-19

Decoded: How Covid-19 vaccine efficacy helps to get an idea of protection

Efficacy of a vaccine means its ability to stimulate immunity in a person who has received the shot

Covaxin shows 81% efficacy in phase-3 trials, says Bharat Biotech

Firm is gearing up to produce 40 million doses a month. Two Bio-safety Level-3 facilities (which can deal with deadly and contagious viruses) have been set up, third is on the way

Covaxin's efficacy shows immense strength of Atmanirbhar Bharat: ICMR chief

Bharat Biotech said that Covaxin had demostrated an interim efficacy of 81 per cent in preventing Covid-19 in late-stage clinical trials

Covaxin showed 81% interim efficacy: Bharat Biotech on Phase 3 results

Covaxin demonstrates significant immunogenicity against the rapidly emerging variants, says Bharat Biotech CMD

PM Modi kicks off third phase of vaccination, takes first jab of Covaxin

In the age group of 45-60 years of age around 18,850 got the first dose and more than 128,000 beneficiaries over 60 years of age got the shot on Monday

Healing a weak regulator

Weaknesses in India's drug regulatory regime and the constraints and questionable decisions of the drug regulator could mar the country's reputation in global markets

PM taking indigenous vaccine should remove doubts on side-effects: Vardhan

Prime Minister Narendra Modi taking an indigenously developed COVID-19 vaccine should remove all doubts that people have about its side-effects, Harsh Vardhan said

Chinese hackers targeted Serum, Bharat Biotech, says security firm

Rivals China and India have both sold or gifted Covid-19 shots to many countries. India produces more than 60 per cent of all vaccines sold in the world

Covid vaccination Phase-II: Check if you are eligible to get a shot

If you are above 45 years old and have one of co-morbidities listed by the govt, you could get a coronavirus vaccine in this phase-2 of vaccination drive. Here's the full list of health issues

Covid-19: CSIR-IICT played key role in developing adjuvant for Covaxin

The process technology developed by the CSIR, IICT for the agonist molecule is playing an important role in the production of adjuvant for Bharat Biotech's COVID-19 vaccine Covaxin, the CSIR said

Bharat Biotech signs deal to send 20 mn Covaxin doses to Brazil

Shipments to be made during second and third quarters of current calendar

Bharat Biotech signs pact to supply 20 mn doses of Covaxin to Brazil

The supply is slated to take place in the second and third quarters of current year

Ukraine keen on Bharat Biotech's Covaxin, sends team to negotiate supply

Three-member delegation led by nation's health minister visits Hyderabad unit, discusses timeline for delivery of shots on priority, and prospects of a tie-up for teh firm;s intranasal vaccine

Top headlines: New corporate pay structure, mapping deregulation, and more

From investor charter presented in the Union Budget to correction in gold prices, here are the top headlines on Tuesday morning

Can re-engineer Covaxin to beat South African variant: Bharat Biotech

Other vaccine makers, such as Hyderabad-based Biological E, too, have started working on different strains.

Bharat Biotech to have phase 3 efficacy data for Covaxin in 2 weeks

The restricted emergency use allowed by the regulator was based on phase 2 safety and immunogenicity studies, as well as data from monkey trials

Madras HC notice to Centre on plea to declare Covishield vaccine as unsafe

The petitioner, 41-year old Asif Riaz, also sought an interim injunction restraining the Central government and the Drugs Controller General of India from continuing with administering Covishield

Bharat Biotech pursues Covid-19 vaccine approval in over 40 countries

The company has also entered into an agreement with U.S. drug developer Ocugen Inc for the commercialization of COVAXIN in the United States, which has seen the most number of infections in the world

Top headlines: Sebi eases listing rules for large IPOs, Bitcoin hits record

A month into the Covid-19 immunisation drive, as many as 21 states and Union Territories (UTs) have not administered a single shot of Covaxin from Bharat Biotech. Read top news with Business Standard